APM

Avidity Partners Management Portfolio holdings

AUM $439M
1-Year Est. Return 34.53%
This Quarter Est. Return
1 Year Est. Return
+34.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$439M
AUM Growth
-$59.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1
+$57.5M
2
+$18.2M
3
+$11.6M
4
PFE icon
Pfizer
PFE
+$9.34M
5
MTSR
Metsera Inc
MTSR
+$7.35M

Top Sells

1
+$20.7M
2
+$18.7M
3
+$18.4M
4
HNGE
Hinge Health
HNGE
+$16.7M
5
EXAS icon
Exact Sciences
EXAS
+$15.4M

Sector Composition

1 Healthcare 99.02%
2 Consumer Staples 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVUE icon
26
Kenvue
KVUE
$33.1B
$4.3M 0.98%
+265,200
IMUX icon
27
Immunic
IMUX
$76.8M
$4.14M 0.94%
4,699,411
-916,400
ARQT icon
28
Arcutis Biotherapeutics
ARQT
$3.23B
$4.04M 0.92%
214,400
-53,600
EXAS icon
29
Exact Sciences
EXAS
$19.4B
$4.03M 0.92%
73,600
-281,400
PHAT icon
30
Phathom Pharmaceuticals
PHAT
$1.17B
$3.6M 0.82%
306,000
-758,500
RGEN icon
31
Repligen
RGEN
$9.1B
$3.11M 0.71%
23,300
-83,200
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.49B
$3.07M 0.7%
+144,000
ASND icon
33
Ascendis Pharma
ASND
$13.1B
$2.88M 0.66%
+14,500
ELVN icon
34
Enliven Therapeutics
ELVN
$1.49B
$2.87M 0.65%
140,300
+129,000
BEAM icon
35
Beam Therapeutics
BEAM
$3.25B
$2.72M 0.62%
112,000
-297,400
SCYX icon
36
SCYNEXIS
SCYX
$26.9M
$2.58M 0.59%
3,350,528
+2,121,618
HQY icon
37
HealthEquity
HQY
$7.43B
$2.4M 0.55%
25,300
-66,700
WVE icon
38
Wave Life Sciences
WVE
$2.61B
$2.18M 0.5%
+297,500
XENE icon
39
Xenon Pharmaceuticals
XENE
$3.15B
$2.14M 0.49%
53,400
-54,491
AKRO
40
DELISTED
Akero Therapeutics
AKRO
$1.92M 0.44%
40,500
-93,500
INSM icon
41
Insmed
INSM
$34B
$1.67M 0.38%
11,600
-47,400
KPTI icon
42
Karyopharm Therapeutics
KPTI
$122M
$880K 0.2%
134,566
IMRX icon
43
Immuneering
IMRX
$300M
$636K 0.14%
+90,900
KZR icon
44
Kezar Life Sciences
KZR
$45.4M
– –
-502,600
MDGL icon
45
Madrigal Pharmaceuticals
MDGL
$11.3B
– –
-19,000
MLTX icon
46
MoonLake Immunotherapeutics
MLTX
$1.16B
– –
-39,000
NTLA icon
47
Intellia Therapeutics
NTLA
$1.37B
– –
-232,000
OGN icon
48
Organon & Co
OGN
$2.26B
– –
-640,000
QURE icon
49
uniQure
QURE
$1.37B
– –
-207,000
RARE icon
50
Ultragenyx Pharmaceutical
RARE
$2.27B
– –
-154,000
1
2
3